Literature DB >> 7929133

Growth stimulus-mediated differential translocation of casein kinase 2 to the nuclear matrix. Evidence based on androgen action in the prostate.

S Tawfic1, K Ahmed.   

Abstract

Recently, we documented that a significant amount of nuclear casein kinase 2 (CK2) (a ubiquitous multipotential messenger-independent serine/threonine protein kinase) is associated with the nuclear matrix (NM), where it may be involved in the phosphorylation of several intrinsic proteins (Tawfic, S., and Ahmed, K. (1994) J. Biol. Chem. 269, 7489-7493). Both CK2 and NM have been implicated in cell growth and proliferation. To examine whether CK2 in the NM was regulated in relation to a growth stimulus, we employed androgen action in the prostate as a model of growth control. In rats, androgen deprivation leads to a differential loss of CK2 activity and protein from the NM fraction in the prostate. At 24 h after androgen deprivation, the NM-associated CK2 activity as well as immunoreactive protein decline by about 80%. By comparison, total nuclear CK2 activity decreased by only 37%. Androgen administration to the castrated rats evokes a rapid differential increase in CK2 activity in the NM, so that within 1 h following the androgenic stimulus, the CK2 activity increases by 110% in the NM fraction versus 45% in the total nuclei. We propose that the stimulus-mediated differential translocation of CK2 to NM may play a role in the transduction of growth signal.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7929133

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Expression and regulation of protein kinase CK2 during the cell cycle.

Authors:  D G Bosc; B Lüscher; D W Litchfield
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  Consequences of CK2 signaling to the nuclear matrix.

Authors:  S Yu; H Wang; A Davis; K Ahmed
Journal:  Mol Cell Biochem       Date:  2001-11       Impact factor: 3.396

Review 3.  Protein kinase CK2--a key suppressor of apoptosis.

Authors:  Kashif A Ahmad; Guixia Wang; Gretchen Unger; Joel Slaton; Khalil Ahmed
Journal:  Adv Enzyme Regul       Date:  2008-04-30

4.  B23 is a downstream target of polyamine-modulated CK2.

Authors:  Kathryn Lawson; Laura Larentowicz; Lisa Laury-Kleintop; Susan K Gilmour
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

5.  Protein B23/nucleophosmin/numatrin nuclear dynamics in relation to protein kinase CK2 and apoptotic activity in prostate cells.

Authors:  Guixia Wang; Yunqian Pan; Kashif A Ahmad; Khalil Ahmed
Journal:  Biochemistry       Date:  2010-05-11       Impact factor: 3.162

6.  Tyrosine kinase-dependent release of an adenovirus preterminal protein complex from the nuclear matrix.

Authors:  P C Angeletti; J A Engler
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

7.  Role of protein kinase CK2 in phosphorylation nucleosomal proteins in relation to transcriptional activity.

Authors:  C Guo; A T Davis; S Yu; S Tawfic; K Ahmed
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

8.  Systemic administration of antisense oligonucleotides simultaneously targeting CK2α and α' subunits reduces orthotopic xenograft prostate tumors in mice.

Authors:  Janeen H Trembley; Gretchen M Unger; Diane K Tobolt; Vicci L Korman; Guixia Wang; Kashif A Ahmad; Joel W Slaton; Betsy T Kren; Khalil Ahmed
Journal:  Mol Cell Biochem       Date:  2011-07-15       Impact factor: 3.396

Review 9.  Protein kinase CK2 in health and disease: CK2: a key player in cancer biology.

Authors:  J H Trembley; G Wang; G Unger; J Slaton; K Ahmed
Journal:  Cell Mol Life Sci       Date:  2009-06       Impact factor: 9.261

10.  Association of elevated protein kinase CK2 activity with aggressive behavior of squamous cell carcinoma of the head and neck.

Authors:  M Gapany; R A Faust; S Tawfic; A Davis; G L Adams; K Ahmed
Journal:  Mol Med       Date:  1995-09       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.